Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Update

Jaguar Health, Inc. (NASDAQ:JAGX) saw a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 636,700 shares, a decline of 18.9% from the January 31st total of 785,100 shares. Based on an average daily trading volume, of 440,200 shares, the days-to-cover ratio is currently 1.4 days. Currently, 5.1% of the shares of the company are sold short.

Jaguar Health Stock Down 2.1 %

NASDAQ JAGX traded down $0.01 during trading hours on Tuesday, reaching $0.56. 124,106 shares of the company were exchanged, compared to its average volume of 431,744. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. Jaguar Health has a 1 year low of $0.55 and a 1 year high of $21.60. The business’s 50 day simple moving average is $0.90 and its 200-day simple moving average is $1.03.

Institutional Investors Weigh In On Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC purchased a new stake in Jaguar Health, Inc. (NASDAQ:JAGX) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health as of its most recent SEC filing. Institutional investors and hedge funds own 12.04% of the company’s stock.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.